Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of Canada and the Canadian Institutes of Health Research, published as a pre-print, demonstrated one dose of Vaxzevria was 82% effective against hospitalisation or death caused by the Beta/Gamma variants of the SARS-CoV-2 virus. The vaccine also showed a high level […]

The post AstraZeneca’s Vaxzevria is highly effective after one dose against severe disease or hospitalisation caused by Beta and Delta variants of concern first appeared on World Pharma Today.